Evidence map›Paper›PMID 35454448›Full record

ArticleMaterials (Basel, Switzerland)2022

Sol-Gel-Derived Fibers Based on Amorphous

Bastian Christ, Walther Glaubitt, Katrin Berberich, Tobias Weigel, Jörn Probst, Gerhard Sextl, Sofia Dembski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bastian ChristFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.
Walther GlaubittFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.
Katrin BerberichFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.
Tobias WeigelFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.ORCID 0000-0002-6343-0505
Jörn ProbstFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.
Gerhard SextlFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.
Sofia DembskiFraunhofer Institute for Silicate Research ISC, Translational Center Regenerative Therapies TLC-RT, Neunerplatz 2, 97082 Würzburg, Germany.
Fraunhofer Institute for Silicate Research · DEUniversitätsklinikum Würzburg · DEUniversity of Würzburg · DE

Funding

Fraunhofer Institute for Silicate Research 664413
6 · The paper itself

Abstract

The development of novel fibrous biomaterials and further processing of medical devices is still challenging. For instance, titanium(IV) oxide is a well-established biocompatible material, and the synthesis of TiO

Indexed as

dry spinningscaffoldsol-gel chemistry

Identifiers

PMID35454448
PMCPMC9024846
OpenAlexW4224260154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.